Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Way too much upside here
View:
Post by justintime1990 on Mar 19, 2021 4:25pm

Way too much upside here

Yes there is still risk, but imagine being first to market with a liquid biopsy. The stock market is a gamble, yes the company has had trouble executing sometimes in the past, but they have been on a hiring spree, they have grown leaps and miles. From the start, they knew this would be a long time coming. Given all these factors and MarketMoney's technical analysis, I'm excited with the amount of shares I've been able to accumulate until now.I love the risk/reward of this stock.
Comment by LithLover on Mar 19, 2021 4:49pm
So Tripp has said Aristotle will roll out in Q1 over and over again in conference calls, in videos and in SEDAR documents.  I have to think that it would be a big misstep to miss this date after calling for a vote of record on the 29th. But in the meantime, why not put out a NR on Covid or an update to say Aristotle is on track? Only thing that makes sense is that Tripp is so confident in ...more  
Comment by justintime1990 on Mar 19, 2021 5:05pm
My honest opinion is that Tripp is a scientist first, and a businessman second. Is that the best for a stock? Meh, probably not, but if the product is groundbreaking and functional and he surrounds himself with a team that can help market, the stock will move. Perphaps once they actually have a product to sell, focus can be on marketing. He has stated, time and time again as you said, this quarter ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities